Defining the Relationship Between Plasma Glucose and HbA1c
Top Cited Papers
Open Access
- 1 February 2002
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (2) , 275-278
- https://doi.org/10.2337/diacare.25.2.275
Abstract
OBJECTIVE— To define the relationship between HbA1c and plasma glucose (PG) levels in patients with type 1 diabetes using data from the Diabetes Control and Complications Trial (DCCT). RESEARCH DESIGN AND METHODS— The DCCT was a multicenter, randomized clinical trial designed to compare intensive and conventional therapies and their relative effects on the development and progression of diabetic complications in patients with type 1 diabetes. Quarterly HbA1c and corresponding seven-point capillary blood glucose profiles (premeal, postmeal, and bedtime) obtained in the DCCT were analyzed to define the relationship between HbA1c and PG. Only data from complete profiles with corresponding HbA1c were used (n = 26,056). Of the 1,441 subjects who participated in the study, 2 were excluded due to missing data. Mean plasma glucose (MPG) was estimated by multiplying capillary blood glucose by 1.11. Linear regression analysis weighted by the number of observations per subject was used to correlate MPG and HbA1c. RESULTS— Linear regression analysis, using MPG and HbA1c summarized by patient (n = 1,439), produced a relationship of MPG (mmol/l) = (1.98 ○1 HbA1c) - 4.29 or MPG (mg/dl) = (35.6 ○1 HbA1c) - 77.3, r = 0.82). Among individual time points, afternoon and evening PG (postlunch, predinner, postdinner, and bedtime) showed higher correlations with HbA1c than the morning time points (prebreakfast, postbreakfast, and prelunch). CONCLUSIONS— We have defined the relationship between HbA1c and PG as assessed in the DCCT. Knowing this relationship can help patients with diabetes and their healthcare providers set day-to-day targets for PG to achieve specific HbA1c goals.This publication has 22 references indexed in Scilit:
- Standards of Medical Care for Patients With Diabetes MellitusClinical Diabetes, 2002
- What's ahead in glucose monitoring?Postgraduate Medicine, 2001
- A Mathematical Model for the Determination of Total Area Under Glucose Tolerance and Other Metabolic CurvesDiabetes Care, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemiaDiabetologia, 1990
- Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research GroupDiabetes Care, 1987
- The Clinical Information Value of the Glycosylated Hemoglobin AssayNew England Journal of Medicine, 1984
- Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetesDiabetologia, 1982
- Glucosebestimmung in hämolysierten Blutprobencclm, 1980
- Further development and automation of a high pressure liquid chromatography method for the determination of glycosylated hemoglobinsMetabolism, 1979